Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) Revenue (2020 - 2025)

Historic Revenue for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to $50.2 million.

  • Treace Medical Concepts' Revenue rose 1137.38% to $50.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $218.9 million, marking a year-over-year increase of 789.6%. This contributed to the annual value of $209.4 million for FY2024, which is 1188.5% up from last year.
  • Latest data reveals that Treace Medical Concepts reported Revenue of $50.2 million as of Q3 2025, which was up 1137.38% from $47.4 million recorded in Q2 2025.
  • Treace Medical Concepts' Revenue's 5-year high stood at $68.7 million during Q4 2024, with a 5-year trough of $18.7 million in Q1 2021.
  • In the last 5 years, Treace Medical Concepts' Revenue had a median value of $42.2 million in 2023 and averaged $41.2 million.
  • Per our database at Business Quant, Treace Medical Concepts' Revenue surged by 16688.2% in 2021 and then skyrocketed by 286.06% in 2025.
  • Quarter analysis of 5 years shows Treace Medical Concepts' Revenue stood at $33.4 million in 2021, then surged by 48.84% to $49.8 million in 2022, then increased by 25.0% to $62.2 million in 2023, then grew by 10.44% to $68.7 million in 2024, then decreased by 26.92% to $50.2 million in 2025.
  • Its Revenue stands at $50.2 million for Q3 2025, versus $47.4 million for Q2 2025 and $52.6 million for Q1 2025.